Overview Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height Status: Completed Trial end date: 2005-08-01 Target enrollment: Participant gender: Summary This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age Phase: Phase 3 Details Lead Sponsor: Pfizer